SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by Hexindai Inc. for the month of December 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on December 27, 2018. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text contains only cover page and signature information. It does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as the document lacks financial data or operational updates beyond the inclusion of a press release.
Guidance, Outlook, and Risks
The provided text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are likely contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Press Release) for the actual financial results and operational updates.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed on the filing.
- Review the full press release for any material risk factors or forward-looking statements not present in the cover page.